Drug-drug interactions in oncology - prevalence and clinical relevance

被引：0
|
作者：
Hinnerkort, A. [1 ,2 ]
Liekweg, A. [1 ]
Muellerleile, U. [3 ]
Tiede, S. [3 ]
Bruellke, N. [3 ]
Jaehde, U. [2 ]
机构：
[1] Asklepios Kliniken Hamburg GmbH, Dept Pharm, Hamburg, Germany
[2] Univ Bonn, Dept Clin Pharm, Inst Pharm, D-5300 Bonn, Germany
[3] Asklepios Klin Barmbek, Dept Oncol & Pallit Med, Hamburg, Germany
来源：
ONKOLOGIE | 2010年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [21] Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer
    Hulskotte, L.
    Topfer, W.
    Reyners, A. K. L.
    Taxis, K.
    Jansman, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S1084 - S1084
  • [22] Prevalence and predictors of potential drug-drug interactions
    Nikolic, Bozana
    Jankovic, Slobodan
    Stojanov, Oliver
    Popovic, Jovan
    CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2014, 9 (02): : 348 - 356
  • [23] Drug-drug interactions in clinical practice
    Depont, Fanny
    Vargas, Frederic
    Dutronc, Herve
    Giauque, Emmanuelle
    Ragnaud, Jean-Marie
    Galperine, Tatiana
    Abouelfath, Abdelilah
    Valentino, Ruddy
    Dupon, Michel
    Hebert, Guillaume
    Moore, Nicholas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (11) : 1227 - 1233
  • [24] Drug-Drug Interactions in a Geriatric Outpatient CohortPrevalence and Relevance
    Linda R. Tulner
    Suzanne V. Frankfort
    George J. P. T. Gijsen
    Jos P. C. M. van Campen
    Cornells H. W. Koks
    Jos H. Beijnen
    Drugs & Aging, 2008, 25 : 343 - 355
  • [25] Concomitant drugs with low risks of drug-drug interactions for use in oncology clinical trials
    Ranchon, Florence
    Vial, Thierry
    Rioufol, Catherine
    Henin, Emilie
    Falandry, Claire
    Freyer, Gilles
    Trillet-Lenoir, Veronique
    Le Tourneau, Christophe
    You, Benoit
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 94 (02) : 189 - 200
  • [26] The Clinical Relevance of Information Sources on Drug-Drug Interaction
    Kaplan, Yusuf Cem
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 25 (01): : 89 - 90
  • [27] Prevalence of potential drug-drug interactions in Slovenia in 2013
    Jazbar, Janja
    Locatelli, Igor
    Kos, Mitja
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (02) : 408 - 409
  • [28] Patients with dementia: prevalence and type of drug-drug interactions
    Munoz-Contreras, Maria Cristina
    Cerda, Begona
    Lopez-Roman, Francisco Javier
    Segarra, Ignacio
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [29] The role of nuclear receptors in pharmacokinetic drug-drug interactions in oncology
    Harmsen, S.
    Meijerman, I.
    Beijnen, J. H.
    Schellens, J. H. M.
    CANCER TREATMENT REVIEWS, 2007, 33 (04) : 369 - 380
  • [30] Phytocannabinoid drug-drug interactions and their clinical implications
    Silva, Daniela Amaral
    Pate, David W.
    Clark, Robert D.
    Davies, Neal M.
    El-Kadi, Ayman O. S.
    Lobenberg, Raimar
    PHARMACOLOGY & THERAPEUTICS, 2020, 215
12345